首页 | 本学科首页   官方微博 | 高级检索  
检索        

基于分子对接技术的常用降糖中药有效成分虚拟筛选
引用本文:林桂源,姚华聪,郑细娜,李晓金,陈超乐,赵肃清,郑杰.基于分子对接技术的常用降糖中药有效成分虚拟筛选[J].中国实验方剂学杂志,2015,21(15):202-206.
作者姓名:林桂源  姚华聪  郑细娜  李晓金  陈超乐  赵肃清  郑杰
作者单位:广东工业大学 轻工化工学院, 广州 510006,广东工业大学 轻工化工学院, 广州 510006,广东工业大学 轻工化工学院, 广州 510006,广东工业大学 轻工化工学院, 广州 510006,广东工业大学 轻工化工学院, 广州 510006,广东工业大学 轻工化工学院, 广州 510006,广东工业大学 轻工化工学院, 广州 510006
基金项目:广东省级大学生创新创业训练计划项目(201411845154);广州市科技计划项目(2013Y2-00081);广东省“千百十”人才项目
摘    要:目的: 运用分子对接技术分析常用降糖中药效应物质基础及其作用机制,为降糖中药现代研究提供理论依据。 方法: 基于文献搜集降糖中药化学成分并构建其结构数据库,以二肽基肽酶-Ⅳ等7个糖尿病治疗靶标为分子对接的研究对象,通过Sybyl软件的Surflex-Dock分子对接模块进行虚拟筛选,以打分函数Total-Score为标准评价中药成分与靶标间相互作用,以Total-Score等于7为阈值,筛选出与各靶标结合较好的化学成分,并与已上市降糖西药进行类药性比较。 结果: 与二肽基肽酶-Ⅳ,糖原合酶激酶-3,过氧化酶增殖因子活化受体γ,α-葡萄糖苷酶,葡萄糖激酶,钠-葡萄糖共转运蛋白2和血管紧张素转化酶能较好结合的化学成分分别有52,28,32,150,47,41,33个。通过虚拟筛选得到的这些小分子化合物与已上市降糖西药具有相似的类药性性质。 结论: 分子对接技术在一定程度上解释了降糖中药的效应物质基础与作用机制,为降糖中药现代研究提供了线索。

关 键 词:糖尿病  治疗靶标  降糖中药  化学成分  分子对接  类药性
收稿时间:2014/10/29 0:00:00

Virtual Screening for Effective Components in Commonly Used Anti-diabetic Traditional Chinese Medicines Based on Molecular Docking Technology
LIN Gui-yuan,YAO Hua-cong,ZHENG Xi-n,LI Xiao-jin,CHEN Chao-le,ZHAO Su-qing and ZHENG Jie.Virtual Screening for Effective Components in Commonly Used Anti-diabetic Traditional Chinese Medicines Based on Molecular Docking Technology[J].China Journal of Experimental Traditional Medical Formulae,2015,21(15):202-206.
Authors:LIN Gui-yuan  YAO Hua-cong  ZHENG Xi-n  LI Xiao-jin  CHEN Chao-le  ZHAO Su-qing and ZHENG Jie
Institution:School of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou 510006, China,School of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou 510006, China,School of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou 510006, China,School of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou 510006, China,School of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou 510006, China,School of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou 510006, China and School of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou 510006, China
Abstract:Objective: To analyze pharmacodynamic material basis and mechanism for commonly used anti-diabetic traditional Chinese medicine by molecular docking technology,in order to provide a theoretical basis for modern studies on anti-diabetic traditional Chinese medicines. Method: Chemical components of anti-diabetic traditional Chinese medicines were collected based on literatures to establish the structure database.With seven diabetes therapeutic targets such as dipeptidyl peptidase-IV as the study objects,virtual screening was conducted by the Surflex-Dock module of Sybyl software.With scoring function Total-Score as the standard,interactions between components of traditional Chinese medicine and targets were evaluated.With the Total-Score value at 7,molecules with high score were screened out to further compared with anti-diabetic western medicines in the market in terms of the drug-likeness. Result: There were 52,28,32,150,47,41 and 33 chemical components well combined with dipeptidyl peptidase-IV,glycogen synthase kinase-3,peroxisome proliferator-activated receptor gamma,alpha-glucosidaseare,glucokinase,sodium glucose cotransporter 2 and angiotensin converting enzyme.These small molecule compounds obtained by virtual screening were similar to the western medicine in the market in terms of the drug-likeness. Conclusion: Molecular docking technology can explain pharmacodynamic material basis and mechanism of anti-diabetic traditional Chinese medicines to some extent and provide clues for modern studies on anti-diabetic traditional Chinese medicines.
Keywords:diabetes  therapeutic target  anti-diabetic traditional Chinese medicine  chemical component  molecular docking  drug likeness
点击此处可从《中国实验方剂学杂志》浏览原始摘要信息
点击此处可从《中国实验方剂学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号